Legal

Disclosures

Effective August 17, 2026. Last updated August 17, 2026.

These disclosures apply to every page of this site and to any investor materials reached through it. They describe the basis on which SESS, Inc. may communicate with you about its offering, the limits that apply to you, and the risks of investing. Please read them in full.

01No offer, no solicitation

No securities regulator has passed on the merits of this offering or the accuracy or adequacy of anything on this site. Any representation to the contrary is unlawful.

02Exemptions relied upon

The securities described on this site are not registered under the Securities Act of 1933 or under any state securities law. They are offered on the basis of exemptions from registration, and different exemptions apply to different investors:

Georgia residents

Offered under the Invest Georgia Exemption, O.C.G.A. § 10-5-11. SESS, Inc. filed its exemption notice with the Georgia Secretary of State Securities Division on August 4, 2026.

Residents of other states

Offered only under Section 4(a)(2) of the Securities Act of 1933, which is available only to accredited investors. If you reside outside Georgia and you are not an accredited investor, this offering is not available to you.

Outside the United States

This offering is not directed to, and is not available to, persons outside the United States.

Because the offering relies on exemptions, SESS, Inc. is not required to provide the disclosure a registered public offering would require, and the securities are not subject to the ongoing reporting obligations that apply to public companies.

03Investment limits

Non-accredited Georgia investors may invest no more than the greater of $10,000 or 10% of their annual income or net worth. This limit is imposed by the Invest Georgia Exemption. It does not apply to accredited investors.

The Invest Georgia Exemption permits SESS, Inc. to raise up to $5,000,000 in any rolling twelve month period. The initial target recorded in the exemption notice is $500,000, and the stated target for the current pre-seed round is $2,000,000. Targets are not guarantees. SESS, Inc. may raise more or less than any stated target, may close in multiple tranches, may extend or shorten the offering period, and may withdraw the offering entirely.

04Self certification of eligibility

Your state of residence and your accredited investor status are self certified through the form on this site. SESS, Inc. relies on your certification and does not independently verify it at that stage. Verification may be required before any investment is accepted. Certifying falsely may cause SESS, Inc. to decline or unwind a proposed investment, and may have consequences for you under applicable law.

05The instrument

The security offered is a pre-money Simple Agreement for Future Equity, referred to as a SAFE. A SAFE is not stock and not debt. You should understand the following before considering one:

• You are not a shareholder. A SAFE is a contractual right to receive equity in the future if a qualifying event occurs. Until conversion you have no voting rights, no dividend rights, and no rights of a stockholder.
• It may never convert. Conversion depends on a future priced financing round or another qualifying event. If that never happens, the SAFE may never convert into anything, and it has no maturity date at which you are repaid.
• It is not a loan. There is no interest, no repayment schedule, and no obligation on SESS, Inc. to return your money.
• Terms are set in the documents, not here. The valuation cap, the discount rate, and the minimum investment are set out in the definitive offering documents. Any figure not stated there is not a term of the offering.
• You will be subordinate. On a liquidation or dissolution, SAFE holders generally rank behind creditors.

06Risk of total loss

07Illiquidity

There is no public market for these securities and none is expected to develop. The securities are subject to transfer restrictions under the definitive documents and under applicable securities laws. You should be prepared to hold your investment indefinitely, and you may be unable to sell it at any price, at any time, even if you need the money.

08Early stage company risks

SESS, Inc. was incorporated on July 20, 2026. Risks include, and are not limited to:

• Limited operating history. There is little historical performance on which to evaluate the company, and no assurance the business model will work.
• Financial information. Financial information provided to you may be unaudited, and may be preliminary or subject to change.
• Need for further capital. The company expects to require additional financing. That financing may be unavailable, or available only on terms that are unfavorable to existing holders.
• Dilution. Future financings, the conversion of SAFEs, and awards under the equity incentive plan will dilute your eventual ownership, potentially substantially.
• Competition. The wellness and supplement market is highly competitive and includes participants with far greater resources.
• Manufacturing and supply. The company depends on third party manufacturing, ingredient supply, and distribution, any of which may be delayed, disrupted, or more expensive than expected.
• Regulatory. Dietary supplements are subject to regulation, including by the Food and Drug Administration and the Federal Trade Commission, covering manufacturing, labeling, and claims. Regulatory action or a change in rules could materially affect the business.
• Intellectual property. Trademark applications may not be granted, and the company may be unable to prevent others from using similar names or formulations.
• Key person dependence. The company depends substantially on Samuel C. Evans and on a small founding team, several of whom are family members. The loss of any of them, or a disagreement among them, could materially harm the business.
• Control. The founders hold a controlling interest and will continue to control the company after this offering. You will have no ability to influence corporate decisions.

This list is a summary and is not complete. The definitive offering documents contain a fuller description of risk factors, and you should read them before investing.

09No health or product claims

Statements on this site about the product are made for the purpose of describing the business to prospective investors. They have not been evaluated by the Food and Drug Administration. The product is not intended to diagnose, treat, cure, or prevent any disease.

10Forward-looking statements

This site contains forward-looking statements. These include any statement that is not a historical fact, such as statements about projections, targets, planned use of proceeds, market size, expected timelines, growth, or future performance. Words such as "expect", "plan", "intend", "target", "anticipate", "believe", "estimate", "may", and "will" often identify them.

Forward-looking statements are based on assumptions that we believe are reasonable as of the date made. They are not guarantees. Actual results may differ materially, and probably will. SESS, Inc. undertakes no obligation to update any forward-looking statement, whether as a result of new information, future events, or otherwise, except as required by law. Do not place undue reliance on them.

11Projections

Any financial projections shown to you were prepared by management, are hypothetical, and rest on assumptions about matters that are inherently uncertain and largely outside the company's control. They have not been examined, compiled, or reviewed by an independent accountant. They are not a prediction of results and should not be relied on as one.

12Third party information

Market data, industry statistics, and research attributed to third parties are believed to be from reliable sources, but SESS, Inc. has not independently verified them and makes no representation as to their accuracy or completeness. Such data is included for context only.

13No advice

SESS, Inc. is not a broker dealer, an investment adviser, or a fiduciary to you. Nothing on this site or in any materials reached through it is investment, legal, tax, or accounting advice, and nothing is a recommendation that any investment is suitable for you. You are urged to consult your own financial, legal and tax advisers before investing, and to rely on your own examination of SESS, Inc. and the terms of the offering.

14Not insured, not guaranteed

These securities are not bank deposits, are not insured by the Federal Deposit Insurance Corporation or any other agency, are not protected by the Securities Investor Protection Corporation, and are not guaranteed by any person or entity. No return of capital and no return on capital is promised or assured.

15Confidentiality of materials

Investor materials made available through this site are confidential. Your obligations in relation to them are set out in section 6 of our Terms of Use, and you should not request access unless you accept them.

16Reservations are not investments

An investment reservation submitted through this site is a non-binding indication of interest. It is not a purchase, not a subscription, and not a commitment by you or by SESS, Inc. No money is collected through this site. You will become an investor only if and when you execute definitive offering documents and your subscription is accepted in writing. SESS, Inc. may decline, reduce, or defer any indicated amount for any reason.

17Currency of information

Information on this site speaks only as of its stated date. SESS, Inc. is under no obligation to update it, and the delivery of any materials does not imply that information is correct at any later date. Some figures presented on this site are preliminary and subject to determination by the board of directors.

18Contact

Entity

SESS, Inc., a Georgia corporation

Location

Atlanta, Georgia, United States

Email

info@vip-safety.com